Loading...
*  Framingham Risk Score
The updated version was modified to include dyslipidemia, age range, hypertension treatment, smoking, and total cholesterol, ...
*  Dyslipidemia
... is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In ... Chou, R; Dana, T; Blazina, I; Daeges, M; Bougatsos, C; Jeanne, TL (18 October 2016). "Screening for Dyslipidemia in Younger ... Prolonged elevation of insulin levels can also lead to dyslipidemia. Likewise, increased levels of O-GlcNAc transferase (OGT) ... may cause dyslipidemia.[citation needed] Physicians and basic researchers classify dyslipidemias in two distinct ways: ...
*  Blood lipids
Durrington P (2003). "Dyslipidaemia". Lancet. 362 (9385): 717-31. doi:10.1016/S0140-6736(03)14234-1. PMID 12957096. ...
*  Partial ileal bypass surgery
Durrington P (2003). "Dyslipidaemia". Lancet. 362 (9385): 717-31. doi:10.1016/S0140-6736(03)14234-1. PMID 12957096. Buchwald H ...
*  Familial hypercholesterolemia
FH is classified as a type 2 familial dyslipidemia. There are five types of familial dyslipidemia (not including subtypes), and ... Durrington P (2003). "Dyslipidaemia". Lancet. 362 (9385): 717-31. doi:10.1016/S0140-6736(03)14234-1. PMID 12957096. Jansen AC, ...
*  Hypercholesterolemia
Chou Roger (9 August 2016). "Screening for Dyslipidemia in Younger Adults: A Systematic Review for the U.S. Preventive Services ... Genest, J; Frohlich, J; Fodor, G; McPherson, R (2003-10-28). "Recommendations for the management of dyslipidemia and the ... Durrington, P (August 2003). "Dyslipidaemia". The Lancet. 362 (9385): 717-31. doi:10.1016/S0140-6736(03)14234-1. PMID 12957096 ... Working Group on Hypercholesterolemia and Other, Dyslipidemias. 169 (9): 921-4. PMC 219626 . PMID 14581310. National ...
*  Epidemiology of metabolic syndrome
Finally, dyslipidemia affects the vast majority (up to 97%) of individuals with diabetes and contributes to their elevated risk ... Diabetic dyslipidemia. Diabetes & Cardiovascular Disease Review. 2006;3:1-4. Schubert CM et al. Predictive ability of childhood ... Of the components of the cardiometabolic syndrome, only the prevalence of dyslipidemia has declined in the United States. ...
*  Omega-3 fatty acid
Wu L, Parhofer KG (December 2014). "Diabetic dyslipidemia". Metabolism: clinical and experimental. 63 (12): 1469-79. doi: ...
*  Hyperlipidemia
It is the most common form of dyslipidemia (which includes any abnormal lipid levels). Lipids (water-insoluble molecules) are ... 2009;20(1):41-9. Thompson, GR (2004). "Management of dyslipidaemia". Heart (British Cardiac Society). 90 (8): 949-55. doi: ... "Screening for Dyslipidemia in Younger Adults: A Systematic Review for the U.S. Preventive Services Task Force". Annals of ...
*  Lipidology
Dyslipidemia Kates, p. 275-276. Therapeutic lipidology, p. vii-viii Books Kates, Morris (1972), Techniques of lipidology; ...
*  ACAT2
"Prediction of genetic risk for dyslipidemia". Genomics. 90 (5): 551-8. doi:10.1016/j.ygeno.2007.08.001. PMID 17919884. Kursula ...
*  Fructose
Basciano H, Federico L, Adeli K (2005). "Fructose, insulin resistance, and metabolic dyslipidemia". Nutrition & Metabolism. 2 ( ... "high intakes of fructose may lead to metabolic complications such as dyslipidaemia, insulin resistance, and increased visceral ...
*  UBE2Z
A study in genetic variants that regulate lipid metabolism and determine the susceptibility to dyslipidemia in Japanese ... "Association of genetic variants with dyslipidemia". Molecular Medicine Reports. 12 (4): 5429-36. doi:10.3892/mmr.2015.4081. ...
*  Insulin resistance
Basciano, Heather; Federico, Lisa; Adeli, Khosrow (2005). "Fructose, insulin resistance, and metabolic dyslipidemia". Nutrition ... and dyslipidemia involving elevated triglycerides, small dense low-density lipoprotein (sdLDL) particles, and decreased HDL ...
*  MBX-8025
According to a press release they are examining its potential use for the treatment of dyslipidemia, metabolic syndrome, type 2 ... "Targeting Mixed Dyslipidemia and Metabolic Syndrome". [permanent dead link]. ... "PPAR-β/δ agonists for Type 2 diabetes and dyslipidemia: An adopted orphan still looking for a home". Expert Opinion on ...
*  Obesity in the Middle East and North Africa
The diseases that were targeted were hyptertension and obesity dyslipidemias. Dietary habits, exercise, and alcohol consumption ...
*  Cholesterylester transfer protein
El Harchaoui K, van der Steeg WA, Stroes ES, Kastelein JJ (August 2007). "The role of CETP inhibition in dyslipidemia". Curr ...
*  Niacin/simvastatin
It is used for the treatment of dyslipidemia. It was approved by the FDA on February 15, 2008. On April 15, 2016, the FDA ...
*  Lipoprotein(a)
Boden WE, Sidhu MS, Toth PP (2014). "The therapeutic role of niacin in dyslipidemia management". J. Cardiovasc. Pharmacol. Ther ...
*  High-density lipoprotein
Benatar JR, Stewart RA (2007). "Is it time to stop treating dyslipidaemia with fibrates?". The New Zealand Medical Journal. 120 ... "Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia". Annals of Internal ... "Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia". The American Journal of Clinical ...
*  Glossary of diabetes
Dyslipidemia (or dyslipidaemia) Abnormal lipid levels in the blood. Includes levels that are too high (triglycerides, LDLs) and ... levels that are too low (HDLs). People with insulin resistance and diabetes often have dyslipidemia. Although the cause-and- ...
*  Atorvastatin
McKenney JM (May 2005). "Efficacy and safety of rosuvastatin in treatment of dyslipidemia". American Journal of Health-System ... The primary uses of atorvastatin is for the treatment of dyslipidemia and the prevention of cardiovascular disease: ... Hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Fredrickson types IIa and IIb) to reduce ...
*  Acquired non-inflammatory myopathy
Prescribed statins for dyslipidemia are associated with muscle toxicity. Symptoms of this muscle toxicity include combinations ...
*  Mark Lathrop
December 2008). "Common variants at 30 loci contribute to polygenic dyslipidemia". Nat. Genet. 41 (1): 56-65. doi:10.1038/ng. ...
*  Genome-wide association study
January 2009). "Common variants at 30 loci contribute to polygenic dyslipidemia". Nature Genetics. 41 (1): 56-65. doi:10.1038/ ...